Montag & Caldwell’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1M | Hold |
4,179
| – | – | 0.24% | 50 |
|
|
2025
Q1 | $973K | Hold |
4,179
| – | – | 0.23% | 52 |
|
|
2024
Q4 | $958K | Sell |
4,179
-158
| -4% | -$36.2K | 0.2% | 51 |
|
|
2024
Q3 | $969K | Buy |
+4,337
| New | +$953K | 0.2% | 52 |
|
|
2024
Q2 | – | Sell |
-2,752
| Closed | -$601K | – | 88 |
|
|
2024
Q1 | $601K | Buy |
2,752
+793
| +40% | +$175K | 0.1% | 61 |
|
|
2023
Q4 | $445K | Sell |
1,959
-7
| -0.4% | -$1.47K | 0.08% | 62 |
|
|
2023
Q3 | $395K | Sell |
1,966
-1,738
| -47% | -$367K | 0.05% | 72 |
|
|
2023
Q2 | $768K | Buy |
3,704
+1,258
| +51% | +$244K | 0.09% | 52 |
|
|
2023
Q1 | $482K | Sell |
2,446
-28
| -1% | -$5.76K | 0.06% | 61 |
|
|
2022
Q4 | $500K | Buy |
2,474
+175
| +8% | +$34.2K | 0.07% | 60 |
|
|
2022
Q3 | $404K | Buy |
2,299
+57
| +3% | +$11.7K | 0.06% | 70 |
|
|
2022
Q2 | $451K | Buy |
2,242
+65
| +3% | +$13.9K | 0.07% | 67 |
|
|
2022
Q1 | $493K | Hold |
2,177
| – | – | 0.05% | 56 |
|
|
2021
Q4 | $588K | Buy |
2,177
+118
| +6% | +$29.2K | 0.06% | 53 |
|
|
2021
Q3 | $498K | Buy |
2,059
+79
| +4% | +$19.9K | 0.05% | 59 |
|
|
2021
Q2 | $469K | Buy |
1,980
+62
| +3% | +$14.1K | 0.04% | 57 |
|
|
2021
Q1 | $420K | Hold |
1,918
| – | – | 0.04% | 59 |
|
|
2020
Q4 | $335K | Hold |
1,918
| – | – | 0.02% | 64 |
|
|
2020
Q3 | $310K | Hold |
1,918
| – | – | 0.02% | 68 |
|
|
2020
Q2 | $274K | Hold |
1,918
| – | – | 0.02% | 66 |
|
|
2020
Q1 | $208K | Buy |
1,918
+10
| +0.5% | +$1.44K | 0.01% | 65 |
|
|
2019
Q4 | $277K | Hold |
1,908
| – | – | 0.01% | 73 |
|
|
2019
Q3 | $275K | Buy |
1,908
+126
| +7% | +$18.4K | 0.01% | 67 |
|
|
2019
Q2 | $265K | Hold |
1,782
| – | – | 0.01% | 68 |
|
|
2019
Q1 | $234K | Buy |
+1,782
| New | +$220K | 0.01% | 70 |
|
|
2018
Q4 | – | Sell |
-2,224
| Closed | -$332K | – | 77 |
|
|
2018
Q3 | $332K | Sell |
2,224
-1,823
| -45% | -$277K | 0.01% | 52 |
|
|
2018
Q2 | $624K | Hold |
4,047
| – | – | 0.02% | 46 |
|
|
2018
Q1 | $562K | Sell |
4,047
-450
| -10% | -$66.1K | 0.02% | 47 |
|
|
2017
Q4 | $616K | Buy |
4,497
+162
| +4% | +$21.4K | 0.02% | 42 |
|
|
2017
Q3 | $562K | Sell |
4,335
-81
| -2% | -$10.8K | 0.02% | 42 |
|
|
2017
Q2 | $585K | Sell |
4,416
-6,507
| -60% | -$797K | 0.02% | 42 |
|
|
2017
Q1 | $1.35M | Sell |
10,923
-12
| -0.1% | -$1.42K | 0.04% | 34 |
|
|
2016
Q4 | $1.21M | Buy |
10,935
+1,894
| +21% | +$210K | 0.03% | 36 |
|
|
2016
Q3 | $1.07M | Buy |
9,041
+5,630
| +165% | +$663K | 0.02% | 39 |
|
|
2016
Q2 | $382K | Buy |
+3,411
| New | +$367K | 0.01% | 86 |
|
Other funds holding LH
Montag & Caldwell's LH Position: Q2 2025 in Review
Montag & Caldwell held its Labcorp (LH) position steady in Q2 2025 at 4,179 shares worth $1.1M. The position accounts for 0.24% of the portfolio, ranked #50.
Montag & Caldwell first reported a position in LH in Q2 2016 and has held it in 35 quarters since. The position peaked at $1.35M in Q1 2017. 974 funds tracked by Wall St. Rank hold LH as of Q2 2025.
- Montag & Caldwell held 4,179 shares of Labcorp worth $1.1M as of Q2 2025.
- Montag & Caldwell left its Labcorp share count unchanged in Q2 2025.
- Labcorp made up 0.24% of Montag & Caldwell's portfolio in Q2 2025, its #50 holding.
- Montag & Caldwell first reported a position in Labcorp in Q2 2016 and has held it in 35 quarters since.
- Montag & Caldwell's Labcorp position peaked at $1.35M in Q1 2017.
- 974 funds tracked by Wall St. Rank held Labcorp as of Q2 2025.
Based on Montag & Caldwell's 13F filing for Q2 2025, filed 15 Aug 2025.